The prostate cancer risk associated with BRCA2 PVs was 26.9% (95% CI, 20.5 to 34.7) by age 80 years and 33.1% (95% CI, 25.5 to 42.2) by age 85 years. The gene discussed is BRCA2; the disease is prostate cancer.